Facing the increasingly severe risk of chronic diseases, we constantly innovate underlying medical technologies and develop innovative medical products to benefit public health with the most accessible cost and the best services
In November 2021, the first blood-glucose meter without finger pricking (free from finger blood calibration)
was approved for marketing in China
The first eye-si AI fundus screening system was approved for marketing in China in August 8, 2020. It’s an AI-aided
diagnostic software for fundus lesions (Class III medical device) based on deep-learning technology.